Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation

<table>Flowchart outlining patient selection process. After patient exclusions, 22 patients were analyzed both at 12 months after initiation of sitagliptin and at the end of followup. DM = diabetes mellitus.</table>

International Journal of Endocrinology

fig1

Figure 1

Figure 1: Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation 